Role of Muscle Ketone Metabolism in Mediating the Metabolic Benefits of Weight Loss

肌肉酮代谢在调节减肥代谢益处中的作用

基本信息

  • 批准号:
    10453740
  • 负责人:
  • 金额:
    $ 11.08万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-09-01 至 2024-07-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY Dietary regimens that promote ketone production are gaining popularity due to their ability to facilitate weight loss and improve metabolic health. Ketones (e.g. acetoacetate and 3-hydroxybutyrate (3OHB)) are produced by the liver and oxidized by the brain and peripheral tissues when glucose is low. Whereas the field has largely focused on the positive effects of ketones on the brain and heart, the role of ketone oxidation in skeletal muscle has been largely overlooked and under investigated. Data from our laboratory suggests that the skeletal muscle is a major site of 3OHB clearance, therefore we postulate that skeletal muscle 3OHB oxidation is necessary for optimal metabolic benefits of ‘ketogenic’ dietary weight loss regimens. To this end, this application links the enzyme that catalyzes the first step of 3OHB oxidation, D-ꞵ-hydroxybutyrate dehydrogenase (BDH1), to improved whole-body glucose metabolism and energy homeostasis due to post-obesity weight loss. The central objective of this proposal is to determine if skeletal muscle BDH1 plays a key role in mediating the health benefits of dietary regimens that promote ketogenesis and weight loss. BDH1 catalyzes a near-equilibrium reaction that couples ketone oxidation to the mitochondrial NAD(H) redox state. Herein, we propose a novel conceptual model that positions BDH1 as a mitochondrial redox buffer that promotes optimal skeletal muscle health during fasting and refeeding. Our conceptual model and central objective will be rigorously tested by the following studies. First, we use a novel mouse model with an inducible skeletal muscle-specific deletion of BDH1 to determine the impact of BDH1 on skeletal muscle mitochondrial bioenergetics and glucose metabolism in response to fasting and refeeding. Second, we will test the hypothesis that muscle BDH1 is required for the metabolic benefits of calorie-restricted feeding of a typical Western diet. Third, we will apply genetic engineering in primary human skeletal muscle cells test the hypothesis that ketone-induced shifts in the myocellular redox state impact glucose uptake and downstream metabolism. Results from these studies will expand our understanding of the functional relevance of skeletal muscle BDH1 and ketone oxidation with the long term goal of identifying new therapeutic targets for the prevention of obesity-induced metabolic disease. Importantly, this project will provide advanced training and mentoring in ketone metabolism, cellular genetic engineering, 13C stable isotope tracing, and computational 13C metabolic flux analysis. The career development plan will be implemented via a team of outstanding mentors including Dr. Muoio (Duke Molecular Physiology Institute, DMPI) as the primary mentor, Dr. Newgard (DMPI) as the co-mentor, and Drs. Zhang (DMPI) and Crawford (UMN) as members of the advisory committee. The DMPI is an ideal environment for training as it contains a diverse team of researchers with expertise in nutrient metabolism and multi-omics technologies; including stable isotope tracing all within a single building. The opportunities for training and career development provided by this award will ensure Dr. Williams has an exceptional start to her independent career as a metabolic researcher.
项目总结

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ashley Silberman Williams其他文献

Ashley Silberman Williams的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ashley Silberman Williams', 18)}}的其他基金

Role of Muscle Ketone Metabolism in Mediating the Metabolic Benefits of Weight Loss
肌肉酮代谢在调节减肥代谢益处中的作用
  • 批准号:
    10668419
  • 财政年份:
    2020
  • 资助金额:
    $ 11.08万
  • 项目类别:
Role of Muscle Ketone Metabolism in Mediating the Metabolic Benefits of Weight Loss
肌肉酮代谢在调节减肥代谢益处中的作用
  • 批准号:
    10670534
  • 财政年份:
    2020
  • 资助金额:
    $ 11.08万
  • 项目类别:
Role of Muscle Ketone Metabolism in Mediating the Metabolic Benefits of Weight Loss
肌肉酮代谢在调节减肥代谢益处中的作用
  • 批准号:
    10039573
  • 财政年份:
    2020
  • 资助金额:
    $ 11.08万
  • 项目类别:
Role of Muscle Ketone Metabolism in Mediating the Metabolic Benefits of Weight Loss
肌肉酮代谢在调节减肥代谢益处中的作用
  • 批准号:
    10245167
  • 财政年份:
    2020
  • 资助金额:
    $ 11.08万
  • 项目类别:
Role of Muscle Ketone Metabolism in Mediating the Metabolic Benefits of Weight Loss
肌肉酮代谢在调节减肥代谢益处中的作用
  • 批准号:
    10888076
  • 财政年份:
    2020
  • 资助金额:
    $ 11.08万
  • 项目类别:
Mitochondrial Protein Acetylation and Energy Metabolism in Muscle
肌肉中线粒体蛋白乙酰化和能量代谢
  • 批准号:
    9408119
  • 财政年份:
    2015
  • 资助金额:
    $ 11.08万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 11.08万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 11.08万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 11.08万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 11.08万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 11.08万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 11.08万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 11.08万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 11.08万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 11.08万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 11.08万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了